173 related articles for article (PubMed ID: 15545016)
1. Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients.
Genedani S; Rasio G; Cortelli P; Antonelli F; Guidolin D; Galantucci M; Fuxe K; Agnati LF
Neurotox Res; 2004; 6(4):327-32. PubMed ID: 15545016
[TBL] [Abstract][Full Text] [Related]
2. Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients.
Aldred S; Mecocci P
Arch Gerontol Geriatr; 2010; 51(1):e16-8. PubMed ID: 19665809
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia.
Bicíková M; Rípová D; Hill M; Jirák R; Havlíková H; Tallová J; Hampl R
Clin Chem Lab Med; 2004 May; 42(5):518-24. PubMed ID: 15202788
[TBL] [Abstract][Full Text] [Related]
4. Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia.
Murialdo G; Barreca A; Nobili F; Rollero A; Timossi G; Gianelli MV; Copello F; Rodriguez G; Polleri A
J Endocrinol Invest; 2001 Mar; 24(3):139-46. PubMed ID: 11314741
[TBL] [Abstract][Full Text] [Related]
5. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
Isobe C; Murata T; Sato C; Terayama Y
Life Sci; 2005 Aug; 77(15):1836-43. PubMed ID: 15935398
[TBL] [Abstract][Full Text] [Related]
6. Relationships between dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels and everyday memory in Alzheimer's disease patients compared to healthy controls.
Carlson LE; Sherwin BB; Chertkow HM
Horm Behav; 1999 Jun; 35(3):254-63. PubMed ID: 10373337
[TBL] [Abstract][Full Text] [Related]
7. Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer's disease (AD).
Leblhuber F; Neubauer C; Peichl M; Reisecker F; Steinparz FX; Windhager E; Dienstl E
Psychopharmacology (Berl); 1993; 111(1):23-6. PubMed ID: 7870929
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer's Disease.
Strac DS; Konjevod M; Perkovic MN; Tudor L; Erjavec GN; Pivac N
Curr Alzheimer Res; 2020; 17(2):141-157. PubMed ID: 32183671
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over.
Birkenhäger-Gillesse EG; Derksen J; Lagaay AM
Ann N Y Acad Sci; 1994 May; 719():543-52. PubMed ID: 8010622
[TBL] [Abstract][Full Text] [Related]
10. Studies on homocysteine plasma levels in Alzheimer's patients. Relevance for neurodegeneration.
Agnati LF; Genedani S; Rasio G; Galantucci M; Saltini S; Filaferro M; Franco R; Mora F; Ferré S; Fuxe K
J Neural Transm (Vienna); 2005 Jan; 112(1):163-9. PubMed ID: 15599614
[TBL] [Abstract][Full Text] [Related]
11. Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.
Montarolo F; Perga S; Martire S; Navone DN; Marchet A; Leotta D; Bertolotto A
Neurotox Res; 2016 Oct; 30(3):338-44. PubMed ID: 27159982
[TBL] [Abstract][Full Text] [Related]
12. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.
Irizarry MC; Gurol ME; Raju S; Diaz-Arrastia R; Locascio JJ; Tennis M; Hyman BT; Growdon JH; Greenberg SM; Bottiglieri T
Neurology; 2005 Nov; 65(9):1402-8. PubMed ID: 16275827
[TBL] [Abstract][Full Text] [Related]
13. Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease.
Heafield MT; Fearn S; Steventon GB; Waring RH; Williams AC; Sturman SG
Neurosci Lett; 1990 Mar; 110(1-2):216-20. PubMed ID: 2325885
[TBL] [Abstract][Full Text] [Related]
14. Rapid column-switching liquid chromatography/mass spectrometric assay for DHEA-sulfate in the plasma of patients with Alzheimer's disease.
Cho SH; Jung BH; Lee WY; Chung BC
Biomed Chromatogr; 2006 Oct; 20(10):1093-7. PubMed ID: 16583455
[TBL] [Abstract][Full Text] [Related]
15. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study.
Ułas J; Weihmuller FB; Brunner LC; Joyce JN; Marshall JF; Cotman CW
J Neurosci; 1994 Nov; 14(11 Pt 1):6317-24. PubMed ID: 7965038
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine and cognitive function in Parkinson's disease.
Licking N; Murchison C; Cholerton B; Zabetian CP; Hu SC; Montine TJ; Peterson-Hiller AL; Chung KA; Edwards K; Leverenz JB; Quinn JF
Parkinsonism Relat Disord; 2017 Nov; 44():1-5. PubMed ID: 28807493
[TBL] [Abstract][Full Text] [Related]
17. Hippocampal perfusion and pituitary-adrenal axis in Alzheimer's disease.
Murialdo G; Nobili F; Rollero A; Gianelli MV; Copello F; Rodriguez G; Polleri A
Neuropsychobiology; 2000; 42(2):51-7. PubMed ID: 10940758
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease: pathophysiological implications of measurement of plasma cortisol, plasma dehydroepiandrosterone sulfate, and lymphocytic corticosteroid receptors.
Armanini D; Vecchio F; Basso A; Milone FF; Simoncini M; Fiore C; Mattarello MJ; Sartorato P; Karbowiak I
Endocrine; 2003 Nov; 22(2):113-8. PubMed ID: 14665714
[TBL] [Abstract][Full Text] [Related]
19. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia.
Näsman B; Olsson T; Bäckström T; Eriksson S; Grankvist K; Viitanen M; Bucht G
Biol Psychiatry; 1991 Oct; 30(7):684-90. PubMed ID: 1835658
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte thiolmethyltransferase: another failed marker for Alzheimer's and Parkinson's diseases.
Hurwitz A; Hubble JP; Glatt SL; Koller WC; Pollack J
Neurology; 1995 Oct; 45(10):1903-6. PubMed ID: 7477990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
